TP53 and neoplasm: Western blot analysis on tumor tissues of CT26-implanted mice showed that LbGP treatment significantly increased the level of γ-H2AX, a marker of DNA damage-associated senescence (Figure S4), as well as the levels of p53/p21 expressions, with more pronounced upregulation in the high-dose group (Figure 6A).